Skip to main content

Table 2 Effects on lipid and glucose values

From: No changes of cholesterol levels with a commercially available glucosamine product in patients treated with lipid lowering drugs: a controlled, randomised, open cross-over trial

 

Vitamineral mean and SD

Simvastatin mean and SD

P-value

s-LDL mmol/L

2.27+0.61

2.30+0.51

0.81 ns

s-HDL mmol/L

1.62+0.55

1.63+0.60

0.86 ns

s-total cholesterol mmol/L

4.69+0.99

4.76+0.96

0.53 ns

s-triglyceridesmmol/L

1.77+0.76

1.83+0.79

0.63 ns

p-glucose mmol/L

6.77+1.90

6.90+1.62

0.70 ns

HbA1c mmol/mol

5.13+1.10

5.09+0.97

0.57 ns

  

Atorvastatin

 

s-LDL mmol/L

2.36+0.65

2.36+0.64

1.00 ns

s-HDL mmol/L

1.55+0.40

1.48+0.40

0.10 ns

s-total cholesterol mmol/L

4.51+0.65

4.40+0.89

0.42 ns

s-triglyceridesmmol/L

1.74+1.05

1.59+0.70

0.39 ns

p-glucose mmol/L

7.39+2.08

7.53+2.16

0.38 ns

HbA1c mmol/mol

5.20+1.13

5.18+1.40

0.90 ns

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us